TG Therapeutics TGTX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's earnings yield?
- TG Therapeutics (TGTX) reported earnings yield of 8.7% in Q1 2026.
- How has TG Therapeutics's earnings yield changed year-over-year?
- TG Therapeutics's earnings yield increased by 1277.5% year-over-year, from 0.6% to 8.7%.
- What is the long-term trend for TG Therapeutics's earnings yield?
- Over 4 years (2020 to 2025), TG Therapeutics's earnings yield has grown at a 25.9% compound annual growth rate (CAGR), from -3.8% to 9.4%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.